CXL in Bullous Keratopathy, Veterinary Use

Picture of Farhad Hafezi

Farhad Hafezi

Chief Scientific and Medical Officer at EMAGine. F.Hafezi is the former chairman of the University of Geneva Eye Clinic and currently serves as Chief Medical Officer of the ELZA Institute in Switzerland and board member of ESCRS.

Clinical Study in Veterinary Ophthalmology

Scientific study on the value of PACK-CXL for the treatment of bullous keratopathy for veterinary use.

Share :